Table 3 Baseline demographic and clinical characteristics of patient groups. IgAN, IgA nephropathy; DC, Disease control; NC, Normal control; GFR, Estimated glomerular filtration rate.

From: Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy

Group

Confirmation cohort

Validation cohort

IgAN

NC

IgAN

DC

NC

no. of subjects

30

30

144

100

67

Sex (M: F)

17:13

17:13

78:66

55:45

33:34

Age (year)

36.30 ± 9.75

36.92 ± 10.27

36.51 ± 10.42

43.72 ± 14.19

38.50 ± 9.16

Proteinuria (g/day)

0.96 (0.81–1.41)

1.35 (0.78–2.22)

3.33 (1.71–5.45)

Serum creatinine (umol/L)

97.55 (78.60–133.30)

99.25 (80.30–125.18)

73.85 (62.03–113.83)

eGFR (ml/min/1.73m2)

70.17 ± 28.98

72.00 ± 27.44

97.55(60.94–114.11)